KDM4C and leukemia: Depleting KDM4A and KDM4C by either shRNA or SD49-7 enhanced trimethylation of H3K9 occupying the promoter of MDM2 and activated p21CIP1 by decreasing MDM2 expression, inhibiting the stemness and proliferation, and activating apoptosis of leukemia cells.